Fetal congenital heart disease and intrauterine growth restriction: A retrospective cohort study

Matthew B. Wallenstein, Lorie M. Harper, Anthony O. Odibo, Kimberly A. Roehl, Ryan E Longman, George A. MacOnes, Alison G. Cahill

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: Fetal congenital heart disease may lead to abnormal fetal growth. Our objective was to estimate the association between fetal congenital heart disease (CHD) and intrauterine growth restriction (IUGR) in an effort to better inform clinical management of continuing pregnancies complicated by fetal congenital heart disease. Methods: In a retrospective cohort study, outcome data was collected from singleton pregnancies undergoing routine anatomic survey at a tertiary medical center between 1990 and 2008. Dedicated research nurses collected information on delivery outcomes in an on-going manner. Subjects with a prenatal diagnosis of fetal CHD were compared to those without CHD. Stratified analyses for isolated fetal CHD and major CHD were performed. The primary outcome was IUGR less than 10th percentile by the Alexander growth standard. Logistic regression was used to adjust for confounding variables and refine the estimates of risk. Results: Among 67,823 patients, there were 193 cases of fetal CHD (0.3%) and 5,669 cases of IUGR (8.4%). Prenatal diagnosis of CHD was associated with an increased risk of IUGR (23.8% vs. 8.5%, adjusted odds ratio [aOR] 3.3, 95% confidence interval [CI] 2.4-4.6), and the risk was greatest in fetuses with major CHD (16.5% vs. 8.5%, aOR 2.1, 95% CI 1.3-3.2). Isolated CHD was also associated with an increased risk of IUGR (17.8% vs. 8.5%, aOR 2.2, 95% CI 1.4-3.7). Conclusion: Patients with a prenatal diagnosis of fetal CHD have a three-fold increase in risk of developing IUGR; patients with isolated fetal CHD are twice as likely to develop IUGR. Based on our findings, serial growth assessment may be a reasonable option for patients with fetal CHD diagnosed at routine anatomic survey.

Original languageEnglish (US)
Pages (from-to)662-665
Number of pages4
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume25
Issue number6
DOIs
StatePublished - Jun 2012
Externally publishedYes

Fingerprint

Fetal Heart
Heart Diseases
Cohort Studies
Retrospective Studies
Growth
Prenatal Diagnosis
Odds Ratio
Confidence Intervals
Pregnancy
Confounding Factors (Epidemiology)
Fetal Development

Keywords

  • Congenital heart disease
  • Intrauterine growth restriction
  • Low birth weight

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Fetal congenital heart disease and intrauterine growth restriction : A retrospective cohort study. / Wallenstein, Matthew B.; Harper, Lorie M.; Odibo, Anthony O.; Roehl, Kimberly A.; Longman, Ryan E; MacOnes, George A.; Cahill, Alison G.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, No. 6, 06.2012, p. 662-665.

Research output: Contribution to journalArticle

Wallenstein, Matthew B. ; Harper, Lorie M. ; Odibo, Anthony O. ; Roehl, Kimberly A. ; Longman, Ryan E ; MacOnes, George A. ; Cahill, Alison G. / Fetal congenital heart disease and intrauterine growth restriction : A retrospective cohort study. In: Journal of Maternal-Fetal and Neonatal Medicine. 2012 ; Vol. 25, No. 6. pp. 662-665.
@article{af8eb2495d964456a236dc35355cff70,
title = "Fetal congenital heart disease and intrauterine growth restriction: A retrospective cohort study",
abstract = "Objective: Fetal congenital heart disease may lead to abnormal fetal growth. Our objective was to estimate the association between fetal congenital heart disease (CHD) and intrauterine growth restriction (IUGR) in an effort to better inform clinical management of continuing pregnancies complicated by fetal congenital heart disease. Methods: In a retrospective cohort study, outcome data was collected from singleton pregnancies undergoing routine anatomic survey at a tertiary medical center between 1990 and 2008. Dedicated research nurses collected information on delivery outcomes in an on-going manner. Subjects with a prenatal diagnosis of fetal CHD were compared to those without CHD. Stratified analyses for isolated fetal CHD and major CHD were performed. The primary outcome was IUGR less than 10th percentile by the Alexander growth standard. Logistic regression was used to adjust for confounding variables and refine the estimates of risk. Results: Among 67,823 patients, there were 193 cases of fetal CHD (0.3{\%}) and 5,669 cases of IUGR (8.4{\%}). Prenatal diagnosis of CHD was associated with an increased risk of IUGR (23.8{\%} vs. 8.5{\%}, adjusted odds ratio [aOR] 3.3, 95{\%} confidence interval [CI] 2.4-4.6), and the risk was greatest in fetuses with major CHD (16.5{\%} vs. 8.5{\%}, aOR 2.1, 95{\%} CI 1.3-3.2). Isolated CHD was also associated with an increased risk of IUGR (17.8{\%} vs. 8.5{\%}, aOR 2.2, 95{\%} CI 1.4-3.7). Conclusion: Patients with a prenatal diagnosis of fetal CHD have a three-fold increase in risk of developing IUGR; patients with isolated fetal CHD are twice as likely to develop IUGR. Based on our findings, serial growth assessment may be a reasonable option for patients with fetal CHD diagnosed at routine anatomic survey.",
keywords = "Congenital heart disease, Intrauterine growth restriction, Low birth weight",
author = "Wallenstein, {Matthew B.} and Harper, {Lorie M.} and Odibo, {Anthony O.} and Roehl, {Kimberly A.} and Longman, {Ryan E} and MacOnes, {George A.} and Cahill, {Alison G.}",
year = "2012",
month = "6",
doi = "10.3109/14767058.2011.597900",
language = "English (US)",
volume = "25",
pages = "662--665",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Fetal congenital heart disease and intrauterine growth restriction

T2 - A retrospective cohort study

AU - Wallenstein, Matthew B.

AU - Harper, Lorie M.

AU - Odibo, Anthony O.

AU - Roehl, Kimberly A.

AU - Longman, Ryan E

AU - MacOnes, George A.

AU - Cahill, Alison G.

PY - 2012/6

Y1 - 2012/6

N2 - Objective: Fetal congenital heart disease may lead to abnormal fetal growth. Our objective was to estimate the association between fetal congenital heart disease (CHD) and intrauterine growth restriction (IUGR) in an effort to better inform clinical management of continuing pregnancies complicated by fetal congenital heart disease. Methods: In a retrospective cohort study, outcome data was collected from singleton pregnancies undergoing routine anatomic survey at a tertiary medical center between 1990 and 2008. Dedicated research nurses collected information on delivery outcomes in an on-going manner. Subjects with a prenatal diagnosis of fetal CHD were compared to those without CHD. Stratified analyses for isolated fetal CHD and major CHD were performed. The primary outcome was IUGR less than 10th percentile by the Alexander growth standard. Logistic regression was used to adjust for confounding variables and refine the estimates of risk. Results: Among 67,823 patients, there were 193 cases of fetal CHD (0.3%) and 5,669 cases of IUGR (8.4%). Prenatal diagnosis of CHD was associated with an increased risk of IUGR (23.8% vs. 8.5%, adjusted odds ratio [aOR] 3.3, 95% confidence interval [CI] 2.4-4.6), and the risk was greatest in fetuses with major CHD (16.5% vs. 8.5%, aOR 2.1, 95% CI 1.3-3.2). Isolated CHD was also associated with an increased risk of IUGR (17.8% vs. 8.5%, aOR 2.2, 95% CI 1.4-3.7). Conclusion: Patients with a prenatal diagnosis of fetal CHD have a three-fold increase in risk of developing IUGR; patients with isolated fetal CHD are twice as likely to develop IUGR. Based on our findings, serial growth assessment may be a reasonable option for patients with fetal CHD diagnosed at routine anatomic survey.

AB - Objective: Fetal congenital heart disease may lead to abnormal fetal growth. Our objective was to estimate the association between fetal congenital heart disease (CHD) and intrauterine growth restriction (IUGR) in an effort to better inform clinical management of continuing pregnancies complicated by fetal congenital heart disease. Methods: In a retrospective cohort study, outcome data was collected from singleton pregnancies undergoing routine anatomic survey at a tertiary medical center between 1990 and 2008. Dedicated research nurses collected information on delivery outcomes in an on-going manner. Subjects with a prenatal diagnosis of fetal CHD were compared to those without CHD. Stratified analyses for isolated fetal CHD and major CHD were performed. The primary outcome was IUGR less than 10th percentile by the Alexander growth standard. Logistic regression was used to adjust for confounding variables and refine the estimates of risk. Results: Among 67,823 patients, there were 193 cases of fetal CHD (0.3%) and 5,669 cases of IUGR (8.4%). Prenatal diagnosis of CHD was associated with an increased risk of IUGR (23.8% vs. 8.5%, adjusted odds ratio [aOR] 3.3, 95% confidence interval [CI] 2.4-4.6), and the risk was greatest in fetuses with major CHD (16.5% vs. 8.5%, aOR 2.1, 95% CI 1.3-3.2). Isolated CHD was also associated with an increased risk of IUGR (17.8% vs. 8.5%, aOR 2.2, 95% CI 1.4-3.7). Conclusion: Patients with a prenatal diagnosis of fetal CHD have a three-fold increase in risk of developing IUGR; patients with isolated fetal CHD are twice as likely to develop IUGR. Based on our findings, serial growth assessment may be a reasonable option for patients with fetal CHD diagnosed at routine anatomic survey.

KW - Congenital heart disease

KW - Intrauterine growth restriction

KW - Low birth weight

UR - http://www.scopus.com/inward/record.url?scp=84861042921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861042921&partnerID=8YFLogxK

U2 - 10.3109/14767058.2011.597900

DO - 10.3109/14767058.2011.597900

M3 - Article

C2 - 21823904

AN - SCOPUS:84861042921

VL - 25

SP - 662

EP - 665

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 6

ER -